A short weigh-in update from the 63 & Counting channel on its latest small loss and the worry about keeping the weight off.
Recap by typeshit. Full story at 63 & Counting.
TIKR points to retatrutide, due for filing in early 2027, and says a pending Seventh Circuit ruling on whether it counts as a biologic could decide 5 vs 12 years of exclusivity.
She lost 7 kilos in her first month, regained it during a month-long break, and now says she's eating more and gaining in week two back.
A shared report on doctors turning to GLP-1 medications for weight loss in some kids. Details are thin, so tap through for the full story.
The author, who holds Novo shares, cites Morgan Stanley's $190 billion obesity market forecast for 2035 and an NIH-funded mouse study on aging.
Caliway Biopharmaceuticals developed CBL-514 to target abdominal fat cells, and researchers say it does more than shrink them. Details on how it works are at the link.
The obesity doctor names three foods he thinks people overlook when trying to lose weight. A quick clip with his picks.
Loading…